Paper34192529
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
Amanat F and 22 others. Cell, 2021. Cited by 259 papers, by iCite.
Cite this record
ConductScience Library. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Papers, record 34192529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34192529
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| COVID-19 Vaccines | Major topic |
| RNA, Messenger | Major topic |
| SARS-CoV-2 | Major topic |
| Spike Glycoprotein, Coronavirus | Major topic |
| Vaccination | Major topic |
| Amino Acid Substitution | |
| Angiotensin-Converting Enzyme 2 | |
| Antibodies, Monoclonal | |
| Antibodies, Neutralizing | |
| Antibody Formation | |
| Binding, Competitive | |
| Humans | |
| Immunoglobulin G | |
| Mutation | |
| Protein Domains | |
| Somatic Hypermutation, Immunoglobulin |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AI141990 | NIAID NIH HHS | United States | U01AI141990 | PubMed and NIH | NIH RePORTER |
| S10 OD026880 | NIH HHS | United States | S10OD026880 | PubMed | NIH RePORTER |
| 75N93019C00051 | NIAID NIH HHS | United States | PubMed | PubMed | |
| U01 AI150747 | NIAID NIH HHS | United States | U01AI150747 | PubMed and NIH | NIH RePORTER |
| HHSN272201400008C | NIAID NIH HHS | United States | PubMed | PubMed | |
| T32 CA009547 | NCI NIH HHS | United States | T32CA009547 | PubMed and NIH | NIH RePORTER |
| HHSN272201400006C | NIAID NIH HHS | United States | PubMed | PubMed |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32425270 | Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. | Cell | 2020 | https://conductscience.org/library/papers/32425270 | PubMed |
| 2 | 33780970 | Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. | Nature | 2021 | https://conductscience.org/library/papers/33780970 | PubMed |
| 3 | 24300384 | Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. | J Vis Exp | 2013 | https://conductscience.org/library/papers/24300384 | PubMed |
| 4 | 32571838 | A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. | Science | 2020 | https://conductscience.org/library/papers/32571838 | PubMed |
| 5 | 24412922 | Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo. | Nat Med | 2014 | https://conductscience.org/library/papers/24412922 | PubMed |
| 6 | 32789006 | scRepertoire: An R-based toolkit for single-cell immune receptor analysis. | F1000Res | 2020 | https://conductscience.org/library/papers/32789006 | PubMed |
| 7 | 32094589 | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. | Nat Microbiol | 2020 | https://conductscience.org/library/papers/32094589 | PubMed |
| 8 | 19247287 | Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19247287 | PubMed |
| 9 | 15608191 | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15608191 | PubMed |
| 10 | 33761326 | N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. | Cell | 2021 | https://conductscience.org/library/papers/33761326 | PubMed |
| 11 | 32555388 | Convergent antibody responses to SARS-CoV-2 in convalescent individuals. | Nature | 2020 | https://conductscience.org/library/papers/32555388 | PubMed |
| 12 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 13 | 33112236 | Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. | Elife | 2020 | https://conductscience.org/library/papers/33112236 | PubMed |
| 14 | 28807998 | Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28807998 | PubMed |
| 15 | 32585083 | An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. | Curr Protoc Microbiol | 2020 | https://conductscience.org/library/papers/32585083 | PubMed |
| 16 | 33232870 | Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. | EBioMedicine | 2020 | https://conductscience.org/library/papers/33232870 | PubMed |
| 17 | 33654292 | SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. | Nat Med | 2021 | https://conductscience.org/library/papers/33654292 | PubMed |
| 18 | 18449194 | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. | Nature | 2008 | https://conductscience.org/library/papers/18449194 | PubMed |
| 19 | 32398876 | A serological assay to detect SARS-CoV-2 seroconversion in humans. | Nat Med | 2020 | https://conductscience.org/library/papers/32398876 | PubMed |
| 20 | 30940710 | Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus. | mBio | 2019 | https://conductscience.org/library/papers/30940710 | PubMed |
Cited by210
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 259 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42911442 | Broad-spectrum aptamers: recent advances in selection strategies, structural mechanisms, and biosensing applications. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42911442 | PubMed |
| 42649161 | Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649161 | PubMed |
| 42571698 | Functional and structural basis of Omicron BA.3.2.1 spike. | Cell Rep | 2026 | https://conductscience.org/library/papers/42571698 | PubMed |
| 42465777 | Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465777 | PubMed |
| 42364994 | Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice. | Nat Commun | 2026 | https://conductscience.org/library/papers/42364994 | PubMed |
| 42240400 | Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies. | J Infect Dis | 2026 | https://conductscience.org/library/papers/42240400 | PubMed |
| 42034652 | Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopes. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42034652 | PubMed |
| 42030951 | Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning. | Cell Rep Methods | 2026 | https://conductscience.org/library/papers/42030951 | PubMed |
| 42022217 | Building better antibody responses: The interplay of infection, vaccination, and immune imprinting. | PNAS Nexus | 2026 | https://conductscience.org/library/papers/42022217 | PubMed |
| 41882251 | Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein. | Sci Rep | 2026 | https://conductscience.org/library/papers/41882251 | PubMed |
| 41818265 | Determinants of natural killer cell-mediated antibody dependent cellular cytotoxicity in SARS-CoV-2 antibodies. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41818265 | PubMed |
| 41756886 | The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response. | bioRxiv | 2026 | https://conductscience.org/library/papers/41756886 | PubMed |
| 41666181 | A SARS-CoV-2 variant-induced NTD-targeting antibody enhances viral infection via a distinctive binding mode. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41666181 | PubMed |
| 41623474 | Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort. | iScience | 2026 | https://conductscience.org/library/papers/41623474 | PubMed |
| 41583464 | Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583464 | PubMed |
| 41387968 | Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41387968 | PubMed |
| 41376258 | SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway. | APMIS | 2025 | https://conductscience.org/library/papers/41376258 | PubMed |
| 41295541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41234640 | SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation. | Iran J Microbiol | 2025 | https://conductscience.org/library/papers/41234640 | PubMed |
| 41103414 | Impact of an aerosolized or intramuscular adenovirus type 5-vectored COVID-19 vaccine on Fc-mediated immune effector functions in a hybrid immunity population. | Front Immunol | 2025 | https://conductscience.org/library/papers/41103414 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| FUZ | 80199 | PubTator's text mining | https://conductscience.org/library/genes/80199 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| MZB1 | 51237 | PubTator's text mining | https://conductscience.org/library/genes/51237 | NCBI Gene |
| PRDM1 | 639 | PubTator's text mining | https://conductscience.org/library/genes/639 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
| XBP1 | 7494 | PubTator's text mining | https://conductscience.org/library/genes/7494 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34192529
GET https://conductscience.org/api/papers/v1/34192529/authors?page=2